Nurix Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Nurix Therapeutics using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-10-09 | $-1.03 | $-0.85 | -21.2 % |
| Q2 | 2025-07-09 | $-0.52 | $-0.75 | 30.7 % |
| Q1 | 2025-04-08 | $-0.67 | $-0.78 | 14.1 % |
| Q4 | 2025-01-28 | $-0.75 | $-0.71 | -5.63 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-10-09 | $7.89M | $17.10M | -53.8 % |
| Q2 | 2025-07-09 | $44.06M | $16.89M | 160.8 % |
| Q1 | 2025-04-08 | $18.45M | $12.71M | 45.2 % |
| Q4 | 2025-01-28 | $13.28M | $12.86M | 3.31 % |
Nurix Therapeutics (NRIX) is scheduled to report earnings on January 27, 2026. The last reported earnings were for reported on October 9, 2025 for Q3.
The Actual EPS was $-1.03, which missed the estimate of $-0.85.
The Actual Revenue was $7.9M, which missed the estimate of $17.1M.
Browse earnings estimates, EPS, and revenue on all stocks.